Mediators of Inflammation / 2020 / Article / Tab 4

Research Article

Plasma and Cellular Forms of Fibronectin as Prognostic Markers in Sepsis

Table 4

Baseline pFN and EDA-FN concentrations in the plasma of patients with sepsis in relation to the APACHE II and SOFA score calculated on admission to the ICU.

pFN (mg/L) valueEDA-FN (mg/L) value
SurvivorsNonsurvivorsSurvivorsNonsurvivors

137.1 (113.4-156.4)106.8 (66.4-122.0)0.0316.7 (4.0-29.5)11.0 (6.0-23.6)0.841
157.0 (153.5-196.7)99.8 (62.7-159.4)0.0294.2 (3.8-12.6)5.8 (2.5-23.1)0.727
152.3 (113.4-168.2)93.1 (56.7-133.6)0.0027.7 (4.0-29.5)7.6 (2.9-21.2)0.584
138.8 (119.3-154.6)109.9 (62.7-166.6)0.4103.9 (3.5-12.2)12.6 (2.8-25.6)0.469

The APACHE II scale: in survivors, 57% of patients had APACHE II ≤20, and 43% had APACHE II >20; in nonsurvivors, the proportions were reversed, i.e., 28% of patients had APACHE II ≤20, and 72% had APACHE II >20 (). The SOFA scale: in survivors, 87% of patients had SOFA ≤12, and 13% had SOFA >12; in nonsurvivors, the proportions were reversed, i.e., 38% of patients had SOFA ≤12, and 62% had SOFA >12 ().

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.